Immunostaining in Mohs micrographic surgery: a review

Abdel Kader El Tal1, Ayad E Abrou, Mark A Stiff

  • 1Dermatology Department, Wayne State University, Dearborn, Michigan, USA.

Abstract

Insights

Immunohistochemical staining techniques enhance Mohs micrographic surgery (MMS) for high-risk skin cancers. These methods offer advantages over traditional staining for diagnosing tumors like melanoma.

Area of Science:

  • Dermatology
  • Surgical Pathology
  • Oncology

Background:

  • Immunoperoxidase staining integration expands Mohs micrographic surgery (MMS) applications.
  • High-risk tumors like lentigo maligna, melanoma, and dermatofibrosarcoma protuberans are now candidates for MMS.
  • Frozen tissue processing benefits from advanced staining techniques.

Purpose of the Study:

  • Review English literature on immunohistochemical staining in MMS.
  • Summarize outcomes of using frozen section immunostaining during MMS.
  • Evaluate the efficacy of various staining techniques in MMS.

Main Methods:

  • Conducted a Medline search using keywords: "Mohs surgery," "staining," "immunostaining," and "immunoperoxidase."
  • Analyzed studies comparing immunohistochemical stains with traditional hematoxylin and eosin.
  • Evaluated specific stains like MART-1, MEL-5, HMB-45, and S100 for melanoma and desmoplastic melanoma.

Main Results:

  • Immunostains generally outperform traditional hematoxylin and eosin in MMS.
  • MART-1 shows crisp staining with less background than MEL-5 for melanoma.
  • S100 is the preferred stain for desmoplastic melanomas.

Conclusions:

  • Immunostaining provides significant advantages in Mohs micrographic surgery.
  • Further large, randomized, prospective studies comparing immunostains are needed.
  • No commercial conflicts of interest were reported by the authors.

Related Concept Videos